Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance
Main Authors: | Rozangela C. Pedrosa, Karina B. Felipe, Danilo Wilhelm Filho |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1372376/full |
Similar Items
-
PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
by: Kunrui Zhu, et al.
Published: (2022-08-01) -
Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade
by: Jong Hyun Lee, et al.
Published: (2019-02-01) -
Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021-08-01) -
Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach
by: Torki A. Zughaibi, et al.
Published: (2021-11-01) -
Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials
by: Choudhary Harsha, et al.
Published: (2020-05-01)